GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Goodrx Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.237 Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx first quarter 00:00:04.237 -- 00:00:10.445 2026 earnings call. As a reminder, today's conference call is being recorded. 00:00:10.445 -- 00:00:14.891 I would now like to introduce your host for today's call, Aubrey Reynolds, Director of 00:00:14.891 -- 00:00:17.614 Investor Relations. Ms. Reynolds, you may begin. 00:00:17.614 -- 00:00:19.614 Thank 00:00:20.278 -- 00:00:25.024 you, Operator. Good morning, everyone, and welcome to GoodRx's earnings conference call 00:00:25.024 -- 00:00:27.554 for the first quarter 2026. 00:00:27.554 -- 00:00:31.659 Joining me today are Wendy Barnes, our Chief Executive Officer, and Chris McGinnis, our 00:00:31.659 -- 00:00:34.082 Chief Financial Officer. 00:00:34.082 -- 00:00:38.067 Before we begin, I'd like to remind everyone that this call will contain forward-looking 00:00:38.067 -- 00:00:39.649 statements. 00:00:39.649 -- 00:00:43.614 All statements made on this call that do not relate to matters of historical fact should 00:00:43.614 -- 00:00:48.360 be considered forward-looking statements, including, without limitation, statements regarding 00:00:48.360 -- 00:00:53.587 management's plans, strategies, goals and objectives, our market opportunity, 00:00:53.587 -- 00:00:58.647 our anticipated financial performance, underlying trends in our business and industry, 00:00:58.647 -- 00:01:02.212 including ongoing changes in the pharmacy ecosystem, 00:01:02.212 -- 00:01:07.218 our value proposition, our long-term growth prospects, our direct and hybrid contracting 00:01:07.218 -- 00:01:11.484 approach, collaborations and partnerships with third parties, including our point of 00:01:11.484 -- 00:01:15.950 sale cash programs and ou...